๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Lenalidomide - Medicines in Ireland

55 authorised products containing Lenalidomide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 55 authorised medicines
MedicineActive substanceLicence holderStatus
Lenalidomide Accord 10 mg hard capsules
EU/1/18/1316/006-007
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 15 mg hard capsules
EU/1/18/1316/008-009
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 2.5 mg hard capsules
EU/1/18/1316/001-002
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 20 mg hard capsules
EU/1/18/1316/010
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 25 mg hard capsules
EU/1/18/1316/011
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 5 mg hard capsules
EU/1/18/1316/003-004
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Accord 7.5 mg hard capsules
EU/1/18/1316/005
Lenalidomide Accord Healthcare S.L.U. โ€”
Lenalidomide Clonmel 10 mg hard capsules
PA0126/320/004
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 15 mg hard capsules
PA0126/320/005
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 2.5 mg hard capsules
PA0126/320/001
Lenalidomide Clonmel Healthcare Ltd Not marketed
Lenalidomide Clonmel 20 mg hard capsules
PA0126/320/006
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 25 mg hard capsules
PA0126/320/007
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 5 mg hard capsules
PA0126/320/002
Lenalidomide Clonmel Healthcare Ltd Marketed
Lenalidomide Clonmel 7.5 mg hard capsules
PA0126/320/003
Lenalidomide Clonmel Healthcare Ltd Not marketed
Lenalidomide Grindeks 10 mg hard capsules
PA22992/004/004
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 15 mg hard capsules
PA22992/004/005
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 2.5 mg hard capsules
PA22992/004/001
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 20 mg hard capsules
PA22992/004/006
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 25 mg hard capsules
PA22992/004/007
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 5 mg hard capsules
PA22992/004/002
Lenalidomide AS Grindeks โ€”
Lenalidomide Grindeks 7.5 mg hard capsules
PA22992/004/003
Lenalidomide AS Grindeks โ€”
Lenalidomide Krka 10 mg hard capsules
EU/1/20/1519/007-008
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 15 mg hard capsules
EU/1/20/1519/009-010
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 2.5 mg hard capsules
EU/1/20/1519/001-002
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 20 mg hard capsules
EU/1/20/1519/011-012
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 25 mg hard capsules
EU/1/20/1519/013-014
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 5 mg hard capsules
EU/1/20/1519/003-004
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Krka 7.5 mg hard capsules
EU/1/20/1519/005-006
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto โ€”
Lenalidomide Mylan 10 mg hard capsules
EU/1/20/1490/009-010
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 15 mg hard capsules
EU/1/20/1490/011-012
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 2.5 mg hard capsules
EU/1/20/1490/001-003
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 20 mg hard capsules
EU/120/1490/013-015
Lenalidomide Mylan IRE Healthcare Limited โ€”
Lenalidomide Mylan 25 mg hard capsules
EU/1/20/1490/016-018
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 5 mg hard capsules
EU/1/20/1490/004-005
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Mylan 7.5 mg hard capsules
EU/1/20/1490/006-008
Lenalidomide Mylan Pharmaceuticals Limited โ€”
Lenalidomide Rowex 10 mg hard capsules
PA0711/302/004
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 15 mg hard capsules
PA0711/302/005
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 2.5 mg hard capsules
PA0711/302/001
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Rowex 20 mg hard capsules
PA0711/302/006
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Rowex 25 mg hard capsules
PA0711/302/007
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 5 mg hard capsules
PA0711/302/002
Lenalidomide Rowex Limited, Marketed
Lenalidomide Rowex 7.5 mg hard capsules
PA0711/302/003
Lenalidomide Rowex Limited, Not marketed
Lenalidomide Teva 10 mg hard capsules
PA1986/051/004
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 15 mg hard capsules
PA1986/051/005
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 20 mg hard capsules
PA1986/051/006
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 25 mg hard capsules
PA1986/051/007
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 5 mg hard capsules
PA1986/051/002
Lenalidomide Teva B.V. Marketed
Lenalidomide Teva 7.5 mg hard capsules
PA1986/051/003
Lenalidomide Teva B.V. Not marketed
Revlimid 10 mg hard capsules
EU/1/07/391/002
Lenalidomide Bristol-Myers Squibb Pharma EEIG โ€”
Revlimid 15 mg hard capsules
EU/1/07/391/003
Lenalidomide Bristol-Myers Squibb Pharma EEIG โ€”
1 2 โ†’
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.